Clinical Trial Update: A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH). [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating macitentan for chronic thromboembolic pulmonary hypertension (CTEPH) in Japanese patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Macitentan (macitentan)

Snippet

Sponsor: Actelion | Conditions: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) | Phase 3 | Status: TERMINATED